Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn’s disease and ulcerative colitis in the United States

Peer Review reports

Original Submission
3 Mar 2022	Submitted	Original manuscript
16 May 2022	Reviewed	Reviewer Report
19 Sep 2022	Reviewed	Reviewer Report
25 Jan 2023	Author responded	Author comments - Theresa Hunter Gibble
Resubmission - Version 2
25 Jan 2023	Submitted	Manuscript version 2
31 Jan 2023	Author responded	Author comments - Theresa Hunter Gibble
Resubmission - Version 3
31 Jan 2023	Submitted	Manuscript version 3
6 Feb 2023	Reviewed	Reviewer Report
11 Feb 2023	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
13 Feb 2023	Editorially accepted
9 Mar 2023	Article published	10.1186/s12876-023-02675-w

Back to article page